GLP-1 Use Hits Record High as Medicare Opens Access to Weight-Loss Drugs

Some Medicare beneficiaries eligible for weight loss drug discounts

The number of Americans taking a GLP-1 drug for weight loss is on the rise. A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just two years ago when just 3% said they were using them. That number could climb even higher as Medicare has cleared the way for some patients to access the drugs. William Brangham discussed more with Juliette Cubanski.

GLP-1 use hits record high as Medicare opens access to weight-loss drugs

The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%.

Record Numbers of Americans Are on GLP-1 Drugs. That's Great News for This Stock.

Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.

GLP-1 Use Reaches Record High as Access Broadens, New Data Shows

The share of Americans using glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss has surged to unprecedented levels, according to reports on rising demand and market forecasts. A new analysis from Goldman Sachs projects the global anti-obesity drug market will reach $114 billion by 2030, up from a prior estimate of $101 billion, driven by faster adoption of oral obesity pills and improved affordability, according to analysts Asad H…